Skip to main content
. 2014 May 16;9(5):e97262. doi: 10.1371/journal.pone.0097262

Figure 1. Patient disposition.

Figure 1

ETV: etravirine. NRTIs, nucleos(t)ide reverse-transcriptase inhibitors. Group A: subjects without virologic failure on or no experience with non-nucleoside reverse-transcriptase inhibitors switched due to adverse effects. Group B: subjects switched after a virological failure on an efavirenz- or nevirapine-based regimen.